Showing results (81-90 of 466) with videos related to
Sort By:
Pageof 47
Plos One|November 9, 2022
Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK BiobankHolly Pavey, Spoorthy Kulkarni, Angela Wood, et al.BMC Pregnancy and Childbirth|October 23, 2019
Methodology for sampling women at high maternal risk in administrative dataJennifer Vanderlaan, Anne Dunlop, Roger Rochat, et al.Biochemical and Biophysical Research Communications|October 11, 2003
Galectin-1 interacts with beta-1 subunit of integrinElena P Moiseeva, Bryan Williams, Alison H Goodall, et al.Hypertension (Dallas, Tex. : 1979)|May 1, 2013
Novel description of the 24-hour circadian rhythms of brachial versus central aortic blood pressure and the impact of blood pressure treatment in a randomized controlled clinical trial: The Ambulatory Central Aortic Pressure (AmCAP) StudyBryan Williams, Peter S Lacy, Fabio Baschiera, et al.Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|April 3, 2019
Associations Between Hospital Maternal Service Level and Delivery OutcomesJennifer Vanderlaan, Roger Rochat, Bryan Williams, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 30, 2014
Effects of exercise on central aortic pressure before and after treatment with renin-angiotensin system blockade in patients with hypertensionPeter S Lacy, Patrick Brunel, Fabio Baschiera, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 10, 2002
Interactive training for the management of breast cancer in general practice in EuropeTorgil Möller, Dino Amadori, George Bellos, et al.Lancet (London, England)|September 15, 2009
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trialMichael A Weber, Henry Black, George Bakris, et al.Lancet (London, England)|May 7, 2017
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phaseAjay Gupta, David Thompson, Andrew Whitehouse, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|August 21, 2016
True Resistant Hypertension Following Observed Drug Ingestion: A Systematic EvaluationJill Bunker, Choon-Lan Chang, Neil Chapman, et al.Pageof 47